Sansure Biotech Inc. (SHA:688289)
China
· Delayed Price · Currency is CNY 19.92
-0.15 (-0.75%)
May 14, 2025, 2:44 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 11.44 billion as of May 14, 2025. Its market cap has increased by 8.92% in one year.
Market Cap
11.44B
Enterprise Value
7.88B
Revenue
1.58B
Ranking
n/a
PE Ratio
43.40
Stock Price
19.92
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 11.44B, a decrease of -75.35%. That is a compound annual growth rate of -25.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 11.52B | -11.36% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | 45.58B | -1.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 325.75B |
| Shenzhen Mindray Bio-Medical Electronics | 280.46B |
| WuXi AppTec | 174.35B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.60B |
| Aier Eye Hospital Group | 121.89B |
| Shanghai United Imaging Healthcare | 113.80B |
| Sichuan Biokin Pharmaceutical | 106.01B |
| Yunnan Baiyao Group Co.,Ltd | 101.99B |